Ilan Ganot, Solid Bio

Sol­id gets an­oth­er shot in DMD gene ther­a­py race as FDA lifts hold. But is it too late to catch Pfiz­er, Sarep­ta?

Things can get mov­ing again in Worces­ter, Mass­a­chu­setts and Gainesville, Flori­da, where Sol­id Bio­sciences op­er­ate their clin­i­cal sites.

Near­ly a year af­ter the FDA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.